# Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

> **NCT01391312** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 40 (actual)

## Conditions studied

- Glabellar Frown Lines

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A
- **DRUG:** normal saline (placebo)

## Key facts

- **NCT ID:** NCT01391312
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01391312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01391312, "Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01391312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*